---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-196505"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:56:36.780568+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Recursion acquires Exscientia in stock deal; director Burrell resigns; Q2 results reported

## Summary
- Recursion to acquire Exscientia via UK scheme of arrangement; Exscientia shareholders get 0.7729 Recursion shares per share.
- Termination fees: Exscientia pays $6.88M if it accepts a superior proposal; Recursion pays $58.77M if it walks.
- Terry-Ann Burrell resigns from board effective Aug 12, 2024; Zachary Bogue appointed Audit Committee Chair.
- Q2 2024 financial results announced; specific figures not provided in this filing but refer to press release.

## SEC filing metadata
- accession: 0001193125-24-196505
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/0001193125-24-196505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/d856792d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-196505
- JSON: https://secwatch.observer/filing/0001193125-24-196505.json
- Plain text: https://secwatch.observer/filing/0001193125-24-196505.txt

## Source-grounded claims
- claim_id: bdf5c2d098
  claim: Terry-Ann Burrell resigned as Director and Chair of Audit Committee at RECURSION PHARMACEUTICALS, INC..
  evidence_excerpt: On August 6, 2024, Terry-Ann Burrell informed the Company’s board of her decision to resign as a member of the Company’s board and Chair of its Audit Committee, effective August 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601830/000119312524196505/0001193125-24-196505-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.